Covid-19 roundup: Pfiz­er, Mod­er­na say Biden's goal of hav­ing 600M dos­es by Ju­ly is with­in sight; EMA to con­sid­er ex­pand­ing remde­sivir au­tho­riza­tion

Pfiz­er and Mod­er­na are on track to de­liv­er a com­bined 220 mil­lion dos­es of their mR­NA vac­cines in the US by the end of March, the com­pa­nies told a con­gres­sion­al com­mit­tee, set­ting them up to of­fer enough shots to vac­ci­nate 300 mil­lion Amer­i­cans by the end of Ju­ly — a goal Pres­i­dent Joe Biden has out­lined in re­cent days.

Pre­vi­ous­ly, sup­ply wasn’t sup­posed to reach that lev­el un­til Sep­tem­ber.

Both drug­mak­ers say the new goal re­flects sig­nif­i­cant ex­pan­sions in their man­u­fac­tur­ing ca­pac­i­ty. And J&J said it could come in with mil­lions of its one-shot vac­cine if the FDA au­tho­rizes that third op­tion fol­low­ing an ad­comm sched­uled lat­er this week.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER